Furthermore, our research demonstrates that the combined assessment of RDW-CV, TT, Mon#, Fib, and Hb holds significant clinical value in evaluating the disease staging of newly diagnosed neuroblastic tumors in children and differentiating them from ganglioneuroma. Here, GSTM1 is linked to neuroblastic tumor.